N-Acetylcysteine (NAC) for Sinusitis: Evidence and Guideline Recommendations

Introduction to NAC Use in Sinusitis

The American Academy of Allergy, Asthma, and Immunology recommends against the use of NAC or other mucolytic agents for sinusitis, stating that their use as prophylaxis for exacerbations of chronic sinusitis is empiric and not supported by clinical data 1, 2

The European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS2020) concluded that data on the effect of muco-active agents in CRS are very limited and the quality of data is insufficient to advise on their use 3
The Cystic Fibrosis Foundation guidelines state that the evidence is insufficient to recommend for or against routinely providing for the chronic use of N-acetylcysteine, even in CF patients where mucolytic therapy might theoretically be more beneficial 4

Intranasal corticosteroids are the most effective medication class for controlling major symptoms of sinusitis, including nasal congestion, rhinorrhea, and inflammation, according to the American Academy of Allergy, Asthma, and Immunology 5, 6
Saline nasal irrigation is recommended for mechanical clearance, as suggested by the American Academy of Allergy, Asthma, and Immunology 1, 2
Appropriate antibiotics are recommended when bacterial infection is documented, as stated by the American Academy of Allergy, Asthma, and Immunology 5
Short-course oral corticosteroids (5-7 days) are recommended for severe cases with marked mucosal edema or nasal polyps, according to the American Academy of Allergy, Asthma, and Immunology 5, 6

The European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS2020) states that data on muco-active agents, including NAC, in chronic rhinosinusitis are very limited, and the quality of evidence is insufficient to advise their use in treatment, as concluded by the European guideline society 7

The American Academy of Otolaryngology-Head and Neck Surgery recommends saline nasal irrigation, such as buffered hypertonic 3-5% saline, as an adjunctive therapy for sinus congestion and inflammation, providing mechanical clearance and modest anti-inflammatory effects 8
The American Academy of Otolaryngology-Head and Neck Surgery suggests the use of analgesics, such as NSAIDs or acetaminophen, for symptomatic relief of facial pain and fever in patients with sinusitis 8, 9
The American Academy of Otolaryngology-Head and Neck Surgery advises against the use of topical decongestants beyond 3-5 days, as they can cause rhinitis medicamentosa (rebound congestion) 8
The American Academy of Otolaryngology-Head and Neck Surgery recommends against the use of antihistamines in non-allergic sinusitis, as they may worsen congestion by drying nasal mucosa 8
The American Academy of Otolaryngology-Head and Neck Surgery states that guaifenesin lacks evidence for symptomatic relief in sinusitis, despite being commonly recommended 8

The American Academy of Allergy, Asthma, and Immunology recommends reducing congestion and inflammation as the therapeutic goal in chronic sinusitis, with evidence showing that temporary worsening of congestion represents treatment failure or medication side effects 10, 11
The American College of Allergy, Asthma, and Immunology suggests that saline irrigation can prevent crusting of secretions in the ostiomeatal complex, facilitating drainage rather than obstruction 11
The American Academy of Otolaryngology recommends avoiding the use of topical decongestants beyond 3-5 days, as they can cause rhinitis medicamentosa, a rebound hyperemia that dramatically worsens congestion 10

The American Academy of Allergy, Asthma, and Immunology recommends treating allergic rhinitis with antihistamines in addition to intranasal corticosteroids, as allergic rhinitis contributes to ostial obstruction 12, 10
The American College of Allergy, Asthma, and Immunology suggests that non-allergic rhinitis requires different management, focused on intranasal corticosteroids rather than antihistamines 12

The strongest guideline evidence consistently emphasizes reducing congestion and inflammation as the therapeutic goal, with no high-quality evidence supporting intentionally increasing congestion as part of treatment 10, 11, 12